Sort   by:  
 Page size 
ProteomicsIdentification of tumor antigens among the HLA peptidomes of Glioblastoma tumors and plasma
Glioblastoma multiforme (GBM) is the most aggressive brain tumor with poor prognosis to most patients. Immunotherapy of GBM is a potentially beneficial treatment option, whose optimal implementation may depend on familiarity with tumor specific antigens, presented as HLA peptides by the GBM cells. F...
ORGANISM(S): Homo Sapiens (ncbitaxon:9606) 
MSV000084343 | MassIVE
ProteomicsIn-depth proteomic profiling of gastric cancer tumor cells uncovers previously unidentified cancer testis antigens
In-depth proteomic profiling of gastric cancer tumor cells uncovers previously unidentified cancer testis antigens
ORGANISM(S): Homo sapiens (Human) 
2024-06-06 | PXD047203 | Pride
[rptep Ocs 
TranscriptomicsCellular Transcriptional Responses to Merkel cell polyomavirus T antigens
Merkel cell polyomavirus (MCV) is clonally integrated in over 80% of Merkel cell carcinomas and mediates tumor development through the expression of viral oncoproteins large T (LT) and small T antigens (sT). Viral integration is associated with signature mutations in the T antigen locus that result ...
ORGANISM(S): Homo sapiens 
2015-09-21 | E-GEOD-68503 | biostudies-arrayexpress
ProteomicsDefining HLA-II ligand processing and binding rules with mass spectrometry enhances cancer epitope prediction
Increasing evidence indicates CD4+ T cells can recognize cancer-specific antigens and control tumor growth. However, it remains difficult to predict the antigens that will be presented by human leukocyte antigen class II molecules (HLA-II) - hindering efforts to optimally target them therapeutically...
ORGANISM(S): Homo Sapiens (ncbitaxon:9606) 
2019-06-18 | MSV000083991 | MassIVE
GenomicsCancer-restricted cryptic antigens are targets for T cell recognition
Cancer-restricted cryptic antigens are targets for T cell recognition
PRJNA1210006 | ENA
TranscriptomicsNext Generation Sequencing (RNAseq) of non-small cell lung cancer
Cancer testis antigens (CTAs) are of clinical interest as biomarkers and present valuable targets for immunotherapy. To comprehensively characterize the CTA landscape of non-small cell lung cancer (NSCLC), we compared RNAseq data of 199 NSCLC tissues to the normal transcriptome of 142 samples from 3...
ORGANISM(S): Homo sapiens 
2016-06-01 | E-GEOD-81089 | biostudies-arrayexpress
GenomicsCancer-restricted cryptic antigens are targets for T cell recognition
Cancer-restricted cryptic antigens are targets for T cell recognition
PRJNA1210005 | ENA
ProteomicsSperm-specific proteins and cancer testis antigens exist outside the blood-testis barrier
Sperm develop in the seminiferous tubules of the testis from puberty, sequestered inside the blood-testis barrier to prevent their recognition as “non-self” by the immune system. It is widely assumed that proteins expressed specifically in sperm do not have direct access to the circulation or the im...
ORGANISM(S): Homo sapiens (Human) Mus musculus (Mouse) 
2021-04-01 | PXD014333 | Pride
Testicular interstitial fluid Cancer-testis antigens Germ cell proteins 
GenomicsPan-cancer tumor-specific antigens and membrane targets from transposable elements
Pan-cancer tumor-specific antigens and membrane targets from transposable elements
PRJNA828030 | ENA
ProteomicsIdentification of tumor antigens in the HLA peptidome of patient-derived xenograft tumors in mouse
Personalized cancer immunotherapy targeting patient-specific cancer/testis (CTA) antigens and neoantigens may benefit from large-scale tumor HLA peptidome (immunopeptidome) analysis, which aims to accurately identify antigens presented by tumor cells. While significant efforts have been invested in ...
ORGANISM(S): Homo sapiens (Human) 
2020-05-27 | PXD016060 | Pride
Patient derived xenograft Tumor antigen Peptidome Hla 
Sort   by:  
 Page size